Boxers, briefs and bacterial vaginosis: how your underwear can affect your health 
The hidden racist history of hair loss 
Eye infections might seem like a minor complaint – but in some cases they can cause blindness and even death 
Honey is said to help with hay fever symptoms – here’s what the research says about this claim 
Industry shutdowns are messy and painful: 4 lessons Australia’s coal sector can learn from car-makers about bowing out 
US Supreme Court Signals Support for Starbucks in Landmark Labor Law Case 
Sitting is bad for your health and exercise doesn’t seem to offset the harmful effects 
Why do young people have such poor mental health? A psychologist explains 
Adidas Unveils Groundbreaking Wheelchair Basketball Uniforms in Collaboration with Adaptive Sports Northwest 
An apple cider vinegar drink a day? New study shows it might help weight loss 
Finland is the happiest country in the world – but our research suggests the rankings are wealth and status-oriented 
Kroger and Albertsons Extend Store Sale to C&S by 166 Stores in Push for Merger Approval 
‘The ghost has taken the spirit of the Moon’: how Torres Strait Islanders predict eclipses 
Gut microbiome: meet Roseburia intestinalis — the energy-producing bacterium that helps us fight against disease 
Bubs Australia will manufacture and distribute Bubs’ Chinese-label goat milk infant formula in China according to new Chinese standards. under an agreement with Heilongjiang Ubeite Dairy Group (HUG).
The new standards will come into effect in February 2023 .
The “ultra-premium” infant formula has been specially developed for Chinese infants using easily-digestible A2 goat-milk protein, sn2 palmitate (OPO), lactoferrin prebiotics, and nucleotides.
HUG has started submission with the State Administration for Market Regulation (SAMR) to renew its registration in line with China’s new GB standards for exclusive use under the Bubs brand.
According to Kristy Carr, Bubs founder and CEO, they have built strong brand trust and loyalty with Chinese families through marketing and selling Bubs English label infant formula products via the crossborder eCommerce channel, which accounts for around 20 percent of total Chinese infant formula sales.
If approved by SAMR, the formula will give Bubs access to the remaining 80 percent of China’s $25.9 billion infant formula market.
Bubs will also enter into a joint venture agreement, where it will hold a 75 percent interest, with Zhitong Health Technology to distribute its Chinese label goat infant formula products.
Bubs Australia expects to launch its product in the second half of FY23, subject to receiving SAMR approval.
